tiprankstipranks
pc:kensa

Kensana Health

Kensana Health is a Canadian phytopharmaceutical company leveraging its proprietary Generation 4 AI-enhanced phytobioreactor platform, EMOB, to develop plant-based medicines. The company focuses on transforming naturally occurring plant compounds into FDA-registered pharmaceuticals, with its first patented formula, KV23a, targeting the global chronic wound market. Kensana's innovative approach integrates AI technology to standardize and convert plant compounds, aiming to establish leadership in the phytopharmaceutical industry.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$120M
Total Amount Raised$120M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$120M
Latest Funding Amount$120M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 19, 2025
Series C
$120.00M

Investors

Investor Name
Funding Round

Related News and Analysis